Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Bayer Goes All In With Asundexian And Pulls Two Other Factor XIa Projects
Potential Xarelto Successor Prioritized
Nov 08 2022
•
By
Kevin Grogan
• Source: Bayer
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Earnings
More from Business